Skip to main content

Oncologists Accepting Cigna in Massachusetts

545 verified oncologists in Massachusetts accept Cigna. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.

Ursula Matulonis

Ursula Matulonis, MD

Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Robert Haddad

Robert Haddad, MD

Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School

Oncology

Boston, MA30+ years
Patrick Ott

Patrick Ott, MD

Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician

Oncology

Boston, MA30+ years
Kenneth Anderson

Kenneth Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Mary-Ellen Taplin

Mary-Ellen Taplin, MD

Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Toni Choueiri

Toni Choueiri, M.D.

Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School

Oncology

Milford, MA20+ years
Ann Lacasce

Ann Lacasce, M.D.

Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. She serves

Oncology

Milford, MA30+ years
Muneeb Ahmed

Muneeb Ahmed, M.D.

Miriam H. Stoneman Professor of Radiology, Harvard Medical School; Chief, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center; Chair of the Imaging Department, Dana-Farber Cancer Institute

Oncology

Boston, MA20+ years
Vincent Ho

Vincent Ho, MD

Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Susana Campos

Susana Campos, MD MPH

Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School

Oncology

Boston, MA30+ years
Suzanne George

Suzanne George, MD

Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA30+ years
Himisha Beltran

Himisha Beltran, MD

Associate Professor of Medicine, Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology; Director of Translational Research, Medical Oncology

Oncology

Boston, MA20+ years
Joseph Antin

Joseph Antin, MD

Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus

Oncology

Boston, MA30+ years
Jennifer Chan

Jennifer Chan, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute

Oncology

Boston, MA20+ years
Geoffrey Shapiro

Geoffrey Shapiro, MD PHD

Senior Vice President, Developmental Therapeutics; Clinical Director, Center for DNA Damage and Repair; Professor of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Robert Soiffer

Robert Soiffer, MD

Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School

Oncology

Boston, MA30+ years
Elizabeth Mittendorf

Elizabeth Mittendorf, M.D.

Professor of Surgery at Harvard Medical School; Robert and Karen Hale Endowed Chair in Surgical Oncology at Brigham and Women's Hospital; Chief of Division of Breast Surgery at Beth Israel Deaconess Medical Center; Co-Leader of the Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute; Co-Leader of the Breast Program for the Dana-Farber/Harvard Cancer Center; President-elect of the American Society of Clinical Oncology (ASCO) 2026-2027

Oncology

Boston, MA30+ years
Matthew Smith

Matthew Smith, MD PHD

Professor of Medicine, Harvard Medical School; Director, Genitourinary Oncology Program, Massachusetts General Hospital Cancer Center

Oncology

Boston, MA30+ years
Harold Burstein

Harold Burstein, MD PHD

Director of Academic Partnerships; Director of Breast Cancer Education

Oncology

Boston, MA30+ years
Stuart Schnitt

Stuart Schnitt, M.D.

Chief of Oncologic Pathology at the Dana-Farber Cancer Institute, Professor of Pathology at Harvard Medical School, and is an internationally recognized ex; Chief of Oncologic Pathology

Oncology

Boston, MA30+ years

Browse oncologists accepting Cigna by city

Drill into a specific Massachusetts city.

Frequently Asked Questions

How do I know these oncologists accept Cigna?
Each profile on this page lists Cigna among its accepted health plans. Plan participation can change — confirm directly with the practice before your visit.
What Cigna plans do these oncologists accept?
Plan-level detail (PPO, HMO, EPO, Medicare Advantage, etc.) varies by specialists. Open a specific provider profile to see the exact Cigna plans they've published as accepted.
What should I look for when picking a oncologist that takes Cigna?
Start with clinical fit. Profiles on this page mention focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Then verify the specific Cigna plan you carry, compare credentials and affiliations, and check whether the profile mentions accepting new patients.
How do I narrow this list to my city?
Use the city links below to drill into a specific market — coverage and wait times vary by region even within the same state.